Athenex, Inc. (ATNX): Price and Financial Metrics

Athenex, Inc. (ATNX)

Today's Latest Price: $15.42 USD

0.23 (1.48%)

Updated Nov 21 6:55pm

Add ATNX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ATNX Stock Summary

  • Athenex Inc's stock had its IPO on June 14, 2017, making it an older stock than merely 6.9% of US equities in our set.
  • With a price/sales ratio of 10.19, Athenex Inc has a higher such ratio than 89.66% of stocks in our set.
  • With a year-over-year growth in debt of 4,018.08%, Athenex Inc's debt growth rate surpasses 98.79% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Athenex Inc are XON, ADAP, FOLD, ERYP, and SYNA.
  • ATNX's SEC filings can be seen here. And to visit Athenex Inc's official web site, go to
ATNX Daily Price Range
ATNX 52-Week Price Range

ATNX Stock Price Chart More Charts

ATNX Price/Volume Stats

Current price $15.42
Prev. close $15.19
Day low $15.04
Day high $15.57
50-day MA $12.10
200-day MA $13.99
52-week high $21.11
52-week low $8.82
Volume 851,400
Avg. volume 610,847
Dividend yield N/A
Market Cap 1.20B

Athenex, Inc. (ATNX) Company Bio

Athenex Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company was founded in 2003 and is based in Buffalo, New York.

ATNX Latest News Stream

Event/Time News Detail
Loading, please wait...

ATNX Latest Social Stream

Loading social stream, please wait...

View Full ATNX Social Stream

ATNX Price Returns

1-mo 38.79%
3-mo 3.98%
6-mo 10.14%
1-year 29.25%
3-year N/A
5-year N/A
YTD 21.51%
2018 -20.19%
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4905 seconds.